NEUROSCIENCE BIOTECHNOLOGY

Advancing neuroscience.
Expanding access.

Rune Healthcare develops differentiated pharmaceutical products and builds international routes to market through focused R&D, licensing, partnering and export operations.

Explore R&D

Our Business

NEUROSCIENCE

Focused development in CNS and psychiatric medicine.

INNOVATION

Differentiated formulations and delivery strategies.

GLOBAL REACH

International pharmaceutical market access.

PARTNERSHIPS

Development, licensing and distribution collaboration.

RUNE HEALTHCARE

Development and commercialisation working together.

Founded in 2003, Rune Healthcare Limited is a neuroscience-focused biotechnology and pharmaceutical company combining product development with international commercialisation.

Our model is built around multiple value-creation routes: product innovation, late- and mid-stage development, commercial licensing and the international globalisation of established pharmaceutical products.

Discover our history →

OUR BUSINESS

A diversified pharmaceutical model.

Export Operations

Globalising approved and established medicines through international distribution partnerships.

Late-Stage Development

Advancing differentiated products toward approval and launch

Mid-Stage Development

In-licensing and developing promising pharmaceutical opportunities.

Early-Stage Innovation

Creating new formulation and drug-delivery concepts around established medicines.

NEUROSCIENCE BIOTECHNOLOGY

Innovation can mean making a proven medicine work better for patients.

Explore R&D

Press releases and company updates.

Rune Healthcare and BDD Pharma Development Services Announce Collaboration to Develop Four New Psychiatric Treatments

August 14, 2026

The collaboration will focus on four differentiated pharmaceutical products intended to address important needs in psychiatric treatment.

Read Press Release →

RUN-247XR Prototype C Achieves Target Product Profile Parameters

June 1, 2023

Following reformulation, Prototype C achieved its target product profile parameters in vitro and in vivo and was ready to progress toward final clinical development, manufacturing scale-up and commercialisation

Read Press Release →

Rune Healthcare Builds Centralised International Pharmaceutical Export Network

January 1, 2022

Rune expanded partnerships with US pharmaceutical companies, using a centralised hub in Turkey and secondary distribution across Eurasia, Africa and South America.

Read Press Release →

About Rune Healthcare

Rune Healthcare Limited is a neuroscience-focused biotechnology and pharmaceutical development company specialising in the identification, development and commercialisation of differentiated medicines. The company combines pharmaceutical R&D with licensing, partnering and international market-access activities.

Advancing neuroscience.Expanding access.

Development and commercialisation working together.

A diversified pharmaceutical model.

Export Operations

Late-Stage Development

Mid-Stage Development

Early-Stage Innovation

Innovation can mean making a proven medicine work better for patients.

Press releases and company updates.

Rune Healthcare and BDD Pharma Development Services Announce Collaboration to Develop Four New Psychiatric Treatments

RUN-247XR Prototype C Achieves Target Product Profile Parameters

Rune Healthcare Builds Centralised International Pharmaceutical Export Network

About Rune Healthcare

Advancing neuroscience.
Expanding access.